# Sonida Senior Living, Inc.: financial statements, quarterly

SNDA · NYSE · CIK 1043000 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/snda.md) · [Financials](/companies/snda/financials.md) · [Filings](/companies/snda/filings.md) · [Insiders](/companies/snda/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/snda/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [64.7](/filings/0001628280-24-047628.md) | [65.7 d](/filings/0001043000-25-000010.md) | [67.4](/filings/0001043000-25-000031.md) | [70.2](/filings/0001043000-25-000072.md) | [74.8](/filings/0001043000-25-000087.md) | [91.9 d](/filings/0001043000-26-000009.md) | [91.9](/filings/0001043000-26-000020.md) | [93.5](/filings/0001043000-26-000032.md) | [98.0](/filings/0001043000-25-000087.md) | [97.7 d](/filings/0001043000-26-000009.md) | [123](/filings/0001043000-26-000020.md) | [208](/filings/0001043000-26-000032.md) |
| Operating income | $m | not reported | not reported | [14.9](/filings/0001043000-25-000031.md) | not reported | not reported | not reported | [20.1](/filings/0001043000-25-000031.md) | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [9.0](/filings/0001628280-23-038986.md) | [9.7 d](/filings/0001628280-24-013376.md) | [8.6](/filings/0001628280-24-022531.md) | [9.0](/filings/0001043000-25-000072.md) | [9.8](/filings/0001043000-25-000087.md) | [9.6 d](/filings/0001043000-26-000009.md) | [9.4](/filings/0001043000-26-000020.md) | [9.3](/filings/0001043000-26-000032.md) | [9.9](/filings/0001043000-25-000087.md) | [10.0 d](/filings/0001043000-26-000009.md) | [12.8](/filings/0001043000-26-000020.md) | [22.5](/filings/0001043000-26-000032.md) |
| Income tax | $m | [0.1](/filings/0001628280-24-047628.md) | [0.0 d](/filings/0001043000-25-000010.md) | [0.1](/filings/0001043000-25-000031.md) | [0.1](/filings/0001043000-25-000072.md) | [0.1](/filings/0001043000-25-000087.md) | [0.0 d](/filings/0001043000-26-000009.md) | [0.1](/filings/0001043000-26-000020.md) | [0.1](/filings/0001043000-26-000032.md) | [0.1](/filings/0001043000-25-000087.md) | [0.1 d](/filings/0001043000-26-000009.md) | [0.2](/filings/0001043000-26-000020.md) | [0.3](/filings/0001043000-26-000032.md) |
| Net income | $m | [(18.4)](/filings/0001628280-24-047628.md) | [(14.6) d](/filings/0001043000-25-000010.md) | [27.0](/filings/0001043000-25-000031.md) | [(9.8)](/filings/0001043000-25-000072.md) | [(13.8)](/filings/0001043000-25-000087.md) | [(5.5) d](/filings/0001043000-26-000009.md) | [(12.5)](/filings/0001043000-26-000020.md) | [(1.6)](/filings/0001043000-26-000032.md) | [(26.9)](/filings/0001043000-25-000087.md) | [(29.8) d](/filings/0001043000-26-000009.md) | [(41.2)](/filings/0001043000-26-000020.md) | [(24.5)](/filings/0001043000-26-000032.md) |
| Diluted EPS | $ per share | [(2.79)](/filings/0001628280-24-047628.md) | not reported | [2.16](/filings/0001043000-25-000031.md) | [(0.86)](/filings/0001043000-25-000072.md) | [(0.98)](/filings/0001043000-25-000087.md) | not reported | [(0.77)](/filings/0001043000-26-000020.md) | [(0.16)](/filings/0001043000-26-000032.md) | [(1.56)](/filings/0001043000-25-000087.md) | not reported | [(2.39)](/filings/0001043000-26-000020.md) | [(0.52)](/filings/0001043000-26-000032.md) |
| Basic EPS | $ per share | [(2.79)](/filings/0001628280-24-047628.md) | not reported | [2.32](/filings/0001043000-25-000031.md) | [(0.86)](/filings/0001043000-25-000072.md) | [(0.98)](/filings/0001043000-25-000087.md) | not reported | [(0.77)](/filings/0001043000-26-000020.md) | [(0.16)](/filings/0001043000-26-000032.md) | [(1.56)](/filings/0001043000-25-000087.md) | not reported | [(2.39)](/filings/0001043000-26-000020.md) | [(0.52)](/filings/0001043000-26-000032.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.6](/filings/0001628280-23-038986.md) | [4.1](/filings/0001043000-25-000010.md) | [24.2](/filings/0001628280-24-022531.md) | [9.5](/filings/0001628280-24-036747.md) | [24.9](/filings/0001628280-24-047628.md) | [17.0](/filings/0001043000-26-000009.md) | [14.0](/filings/0001043000-25-000031.md) | [14.1](/filings/0001043000-25-000072.md) | [17.0](/filings/0001043000-25-000087.md) | [11.0](/filings/0001043000-26-000032.md) | [84.3](/filings/0001043000-26-000020.md) | [48.7](/filings/0001043000-26-000032.md) |
| Current assets | $m | [33.6](/filings/0001628280-23-038986.md) | [32.3](/filings/0001043000-25-000010.md) | [53.6](/filings/0001628280-24-022531.md) | [40.2](/filings/0001628280-24-036747.md) | [164](/filings/0001628280-24-047628.md) | [64.1](/filings/0001043000-26-000009.md) | [53.7](/filings/0001043000-25-000031.md) | [63.5](/filings/0001043000-25-000072.md) | [72.5](/filings/0001043000-25-000087.md) | [77.9](/filings/0001043000-26-000032.md) | [147](/filings/0001043000-26-000020.md) | [110](/filings/0001043000-26-000032.md) |
| Total assets | $m | [629](/filings/0001628280-23-038986.md) | [621](/filings/0001043000-25-000010.md) | [636](/filings/0001628280-24-022531.md) | [652](/filings/0001628280-24-036747.md) | [796](/filings/0001628280-24-047628.md) | [842](/filings/0001043000-26-000009.md) | [824](/filings/0001043000-25-000031.md) | [850](/filings/0001043000-25-000072.md) | [855](/filings/0001043000-25-000087.md) | [845](/filings/0001043000-26-000032.md) | [2,627](/filings/0001043000-26-000020.md) | [2,549](/filings/0001043000-26-000032.md) |
| Current liabilities | $m | [120](/filings/0001628280-23-038986.md) | [101](/filings/0001043000-25-000010.md) | [56.5](/filings/0001628280-24-022531.md) | [53.6](/filings/0001628280-24-036747.md) | [70.3](/filings/0001628280-24-047628.md) | [75.6](/filings/0001043000-26-000009.md) | [71.0](/filings/0001043000-25-000031.md) | [74.6](/filings/0001043000-25-000072.md) | [104](/filings/0001043000-25-000087.md) | [105](/filings/0001043000-26-000032.md) | [334](/filings/0001043000-26-000020.md) | [125](/filings/0001043000-26-000032.md) |
| Total liabilities | $m | [686](/filings/0001628280-23-038986.md) | [688](/filings/0001043000-25-000010.md) | [628](/filings/0001628280-24-022531.md) | [635](/filings/0001628280-24-036747.md) | [660](/filings/0001628280-24-047628.md) | [712](/filings/0001043000-26-000009.md) | [709](/filings/0001043000-25-000031.md) | [736](/filings/0001043000-25-000072.md) | [768](/filings/0001043000-25-000087.md) | [789](/filings/0001043000-26-000032.md) | [1,738](/filings/0001043000-26-000020.md) | [1,683](/filings/0001043000-26-000032.md) |
| Long-term debt | $m | [565](/filings/0001628280-23-038986.md) | [587](/filings/0001043000-25-000010.md) | [571](/filings/0001628280-24-022531.md) | [582](/filings/0001628280-24-036747.md) | [590](/filings/0001628280-24-047628.md) | [636](/filings/0001043000-26-000009.md) | [636](/filings/0001043000-25-000031.md) | [660](/filings/0001043000-25-000072.md) | [663](/filings/0001043000-25-000087.md) | [682](/filings/0001043000-26-000032.md) | [1,404](/filings/0001043000-26-000020.md) | [1,555](/filings/0001043000-26-000032.md) |
| Current portion of debt | $m | [64.3](/filings/0001628280-23-038986.md) | [42.3](/filings/0001043000-25-000010.md) | [6.8](/filings/0001628280-24-022531.md) | [2.2](/filings/0001628280-24-036747.md) | [14.1](/filings/0001628280-24-047628.md) | [15.5](/filings/0001043000-26-000009.md) | [14.6](/filings/0001043000-25-000031.md) | [17.7](/filings/0001043000-25-000072.md) | [21.0](/filings/0001043000-25-000087.md) | [7.3](/filings/0001043000-26-000032.md) | [219](/filings/0001043000-26-000020.md) | [16.1](/filings/0001043000-26-000032.md) |
| Shareholders' equity | $m | [(104)](/filings/0001628280-23-038986.md) | [(115)](/filings/0001043000-25-000010.md) | [(41.4)](/filings/0001628280-24-036747.md) | [(34.1)](/filings/0001628280-24-036747.md) | [77.5](/filings/0001628280-24-047628.md) | [71.8](/filings/0001043000-26-000009.md) | [58.8](/filings/0001043000-25-000031.md) | [56.7](/filings/0001043000-25-000072.md) | [29.8](/filings/0001043000-25-000087.md) | [(0.0)](/filings/0001043000-26-000032.md) | [885](/filings/0001043000-26-000020.md) | [862](/filings/0001043000-26-000032.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [5.1 d](/filings/0001628280-24-047628.md) | [0.0 d](/filings/0001043000-25-000010.md) | [(4.1)](/filings/0001043000-25-000031.md) | [2.5 d](/filings/0001043000-25-000072.md) | [3.0 d](/filings/0001043000-25-000087.md) | [(3.1) d](/filings/0001043000-26-000009.md) | [3.8](/filings/0001043000-26-000020.md) | [8.9 d](/filings/0001043000-26-000032.md) | [12.0 d](/filings/0001043000-25-000087.md) | [(0.4) d](/filings/0001043000-26-000009.md) | [(35.9)](/filings/0001043000-26-000020.md) | [8.7 d](/filings/0001043000-26-000032.md) |
| Capital expenditure | $m | [4.5 d](/filings/0001628280-24-047628.md) | [3.8 d](/filings/0001043000-25-000010.md) | [5.8](/filings/0001043000-25-000031.md) | [4.1 d](/filings/0001043000-25-000072.md) | [8.0 d](/filings/0001043000-25-000087.md) | [7.2 d](/filings/0001043000-26-000009.md) | [8.3](/filings/0001043000-26-000020.md) | [7.0 d](/filings/0001043000-26-000032.md) | [9.0 d](/filings/0001043000-25-000087.md) | [8.9 d](/filings/0001043000-26-000009.md) | [6.8](/filings/0001043000-26-000020.md) | [12.4 d](/filings/0001043000-26-000032.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [6.4](/filings/0001628280-23-038986.md) | [7.2](/filings/0001628280-24-022531.md) | [6.4](/filings/0001628280-24-036747.md) | [7.1](/filings/0001628280-24-047628.md) | [10.6](/filings/0001043000-25-000031.md) | [13.0](/filings/0001043000-25-000072.md) | [15.5](/filings/0001043000-25-000087.md) | [18.0](/filings/0001043000-26-000020.md) | [18.1](/filings/0001043000-26-000032.md) | [18.1](/filings/0001043000-25-000087.md) | [25.7](/filings/0001043000-26-000020.md) | [46.8](/filings/0001043000-26-000032.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 48,047,990 at 2026-08-07, from the cover of the [10-Q filed 2026-08-10](/filings/0001043000-26-000032.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.